Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 12, 2012, Pages 1487-1493

  Radbill, Andrew E ^a   Triedman, John K ^b   Berul, Charles I ^c   Walsh, Edward P ^b   Alexander, Mark E ^b   Webster, Gregory ^d   Cecchin, Frank ^b  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

implantable device defibrillation; implantable devices pacemaker bradyarrhythmias; pediatrics electrophysiology; pediatrics implantable devices

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIAC CHANNELOPATHY; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONGENITAL HEART DISEASE; DEFIBRILLATION; DEFIBRILLATION THRESHOLD; ELECTRIC POTENTIAL; HEART DISEASE; HEART PACING; HEART RHYTHM; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PILOT STUDY; PROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; CARDIAC PACING, ARTIFICIAL; CHILD; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; ELECTRIC COUNTERSHOCK; FEMALE; HEART DISEASES; HUMANS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870866768     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03519.x     Document Type: Article

References (24)

1. Silka MJ, Hardy BG, Menashe VD, Morris CD. A populationbased prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32:245-251
2. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008; 117:2184-2191.
3. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry. Circulation 2007; 115:773-781.
4. Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993; 87:800-807.
5. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51:1685-1691.
6. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004; 15:72-76.
7. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, Gasparini M, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010; 122:1272-1282.
8. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007; 298:405-412.
9. Dubin AM, Berul CI, Bevilacqua LM, Collins KK, Etheridge SP, Fenrich AL, Friedman RA, et al. The use of implantable cardioverterdefibrillators in pediatric patients awaiting heart transplantation. J Card Fail 2003; 9:375-379.
10. Berul CI. Defibrillator indications and implantation in young children. Heart Rhythm 2008; 5:1755-1757.
11. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006; 17:41-46.
12. Radbill AE, Triedman JK, Berul CI, Fynn-Thompson F, Atallah J, Alexander ME, Walsh EP, et al. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm 2010; 7:193-198.
13. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007; 30:675-700.
14. Heersche JH, Blom NA, van de Heuvel F, Blank C, Reimer AG, Clur SA, Witsenburg M, et al. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Pacing Clin Electrophysiol 2010; 33:179-185.
15. Botsch MP, Franzbach B, Opgen-Rhein B, Berger F, Will JC. ICD therapy in children and young adults: Low incidence of inappropriate shock delivery. Pacing Clin Electrophysiol 2010; 33:734-741.
16. Goel AK, Berger S, Pelech A, Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004; 25:370-378.
17. Tomaske M, Pretre R, Rahn M, Bauersfeld U. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years. Europace 2008; 10:1152-1156.
18. Cannon BC, Friedman RA, Fenrich AL, Fraser CD, McKenzie ED, Kertesz NJ. Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart. Pacing Clin Electrophysiol 2006; 29:181-187.
19. Hsia TY, Bradley SM, LaPage MJ,Whelan S, Saul JP, Ringewald JM, Reed JH. Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: A useful approach to arrhythmia therapy in children. Ann Thorac Surg 2009; 87:1234-1238.
20. Stefanelli CB, Bradley DJ, Leroy S, Dick M 2nd, Serwer GA, Fischbach PS. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol 2002; 6:235-244.
21. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, et al. An entirely subcutaneous implantable cardioverterdefibrillator. N Engl J Med 2010; 363:36-44.
22. Jolley M, Stinstra J, Tate J, Pieper S,Macleod R, Chu L,Wang P, et al. Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Heart Rhythm 2010; 7:692-698.
23. Stephenson EA, Cecchin F, Walsh EP, Berul CI. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations. J Cardiovasc Electrophysiol 2005; 16:69-73.
24. Tokano T, Pelosi F, Flemming M, Horwood L, Souza JJ, Zivin A, Knight BP, et al. Long-term evaluation of the ventricular defibrillation energy requirement. J Cardiovasc Electrophysiol 1998; 9:916-920.